We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Cardiology

Journal Scan / Research · May 27, 2021

Finerenone Reduces Onset of Atrial Fibrillation in Patients With Chronic Kidney Disease and Type 2 Diabetes

Journal of the American College of Cardiology

 

Additional Info

Journal of the American College of Cardiology
Finerenone Reduces Onset of Atrial Fibrillation in Patients With Chronic Kidney Disease and Type 2 Diabetes
J Am Coll Cardiol 2021 May 04;[EPub Ahead of Print], G Filippatos, GL Bakris, B Pitt, R Agarwal, P Rossing, LM Ruilope, J Butler, CSP Lam, P Kolkhof, L Roberts, C Tasto, A Joseph, SD Anker

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading